Translation, cross-cultural adaptation, and analysis of the measurement properties of the Brazilian Portuguese version of the spinal cord injury pain instrument

Spinal Cord, 2022 · DOI: https://doi.org/10.1038/s41393-022-00800-2 · Published: April 12, 2022

Simple Explanation

This study translated and adapted the Spinal Cord Injury Pain Instrument (SCIPI) into Brazilian Portuguese. The goal was to ensure the translated version accurately measures neuropathic pain in Brazilian patients with spinal cord injuries. The study confirmed that the Brazilian Portuguese SCIPI is a reliable and valid tool for identifying neuropathic pain in this population.

Study Duration

Not specified

Participants

100 patients with spinal cord injury sequelae and pain report

Evidence Level

Questionnaire validity study

Key Findings

1
The Brazilian version of the SCIPI demonstrated adequate structural validity, confirming its one-dimensional structure.
2
The SCIPI showed significant correlations with the Douleur Neuropathique 4 (DN4), indicating construct validity.
3
The Brazilian version of the SCIPI has measurement properties suitable for measuring neuropathic pain related to spinal cord injury.

Research Summary

The study successfully translated and adapted the SCIPI for use in Brazil. The adapted SCIPI demonstrated strong reliability and validity in assessing neuropathic pain among individuals with spinal cord injuries. The Brazilian version of the SCIPI can be used to accurately screen for neuropathic pain in clinical settings.

Practical Implications

Clinical Practice

The Brazilian Portuguese SCIPI can be used by clinicians to screen for neuropathic pain in patients with spinal cord injuries.

Research

The validated SCIPI provides a tool for researchers to study neuropathic pain in Brazilian populations with spinal cord injuries.

Improved Diagnosis

Accurate screening with the SCIPI can lead to more appropriate and effective pain management strategies.

Study Limitations

1
Diagnostic evaluation during accuracy assessment not performed by physicians specializing in neuropathic pain.
2
Inter-examiner reliability was not tested.
3
The pre-ﬁnal test phase was performed in only 10 patients due to the COVID-19 pandemic.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury